CNS-focused biopharma (depression, migraine)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 55 | Added +116% | 125,808 | $23,197,737 | 0.1% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -69% | 8,600 | $1,585,754 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -54% | 220,374 | $40,634,762 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.